Cite
HARVARD Citation
Lundkvist, P. et al. (2017). Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year. Diabetes, obesity & metabolism. 19 (9), pp. 1276-1288. [Online].